Telangana DCA Cracks Down on Online Pharmacy Partners After Statewide Inspections

Regulatory officials have issued show-cause notices to 41 medical shops following a sweeping enforcement drive aimed at ensuring compliance with safety standards.

The Telangana Drugs Control Administration (DCA) has launched a significant regulatory push against pharmacies integrated with digital delivery platforms. Following a coordinated special enforcement drive conducted on June 6, officials scrutinized 166 medical shops across the state to determine whether their operations align with the Drugs and Cosmetics Act, 1940. This operation specifically targeted 159 establishments affiliated with online medicine delivery services and seven others linked to business-to-business (B2B) digital marketplaces like IndiaMART.

Systematic Violations Uncovered

The inspections revealed a concerning pattern of administrative and safety lapses. According to findings released by the DCA, the 41 medical shops that received show-cause notices failed to meet basic statutory requirements. Common irregularities included the absence of mandatory sales bills and a failure to maintain crucial purchase invoices. Perhaps more alarmingly, investigators discovered that several outlets were dispensing prescription-only medications without verifying valid prescriptions from registered medical practitioners.

The regulatory audit also exposed widespread gaps in inventory tracking. Many shops were found to be neglecting the maintenance of Schedule H1 drug registers and general prescription drug logs. Furthermore, the DCA noted that some establishments were operating without the required supervision of a registered pharmacist, a direct violation of safety protocols designed to prevent the misuse of pharmaceutical products.

Ensuring Patient Safety

This enforcement action underscores the growing friction between traditional drug regulatory frameworks and the rapid expansion of the digital healthcare ecosystem. By holding online-linked medical shops accountable for the same standards as brick-and-mortar pharmacies, the Telangana DCA is signaling that convenience cannot come at the cost of patient safety. The agency emphasized that all entities, regardless of their digital platform partnerships, must strictly adhere to the established legal provisions.

The DCA has confirmed that the 41 establishments receiving notices are now under formal scrutiny. While the current phase focuses on administrative compliance, the department has warned that further legal action will follow if these outlets fail to rectify their operational deficiencies. As digital pharmacy models continue to gain traction, such rigorous inspections serve as a vital check to ensure that the medication supply chain remains transparent and fully regulated across the state.